Pfizer (PFE) will buy cancer specialist Seagen (SGEN) for roughly $43 billion as Sanofi (SNY) takes over Provention Bio (PRVB) for about $2.9 billion, the companies announced Monday. In response, SGEN...
Tag: SGEN
ILMN, FRC, SGEN & More
Offices of Illumina, in San Diego, California. Mike Blake | Reuters Check out the companies making headlines before the bell. First Republic — Shares of First Republic cratered more than 64% before th...
Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech’s stock pops 20%
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to ...
SGEN Stock Rockets As Yet Another Big Pharma Reportedly Considers A Takeover
Pfizer (PFE) is in early talks to acquire cancer specialist Seagen (SGEN), according to a report that sent SGEN stock flying on Monday. X If true, it would help Pfizer add to its lineup of cancer trea...
Stocks making the biggest moves premarket: BBY, SGEN, UNP
Customers shop at a Best Buy store on August 24, 2021 in Chicago, Illinois. Scott Olson | Getty Images Check out the companies making headlines before the bell. Union Pacific — Shares rose 9.5% after ...
SGEN Stock: Merck’s Rumored Takeover Hits A Snag On Price
Merck‘s (MRK) rumored takeover of cancer-focused biotech Seagen (SGEN) has stalled on price, according to a report Friday that sent SGEN stock tumbling. X So far, the companies have failed to ag...
Merck Looks Attractive, With or Without Seagen
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion
Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...
Merck Pushes Forward With Potential Deal for Seagen
Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year. The Wall Stre...